PMVP
Price
$1.02
Change
+$0.02 (+2.00%)
Updated
Apr 17 closing price
Capitalization
52.97M
19 days until earnings call
XNCR
Price
$9.70
Change
+$0.18 (+1.89%)
Updated
Apr 17 closing price
Capitalization
683.48M
19 days until earnings call
Ad is loading...

PMVP vs XNCR

Header iconPMVP vs XNCR Comparison
Open Charts PMVP vs XNCRBanner chart's image
PMV Pharmaceuticals
Price$1.02
Change+$0.02 (+2.00%)
Volume$89.4K
Capitalization52.97M
Xencor
Price$9.70
Change+$0.18 (+1.89%)
Volume$614.28K
Capitalization683.48M
PMVP vs XNCR Comparison Chart
Loading...
PMVP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PMVP vs. XNCR commentary
Apr 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PMVP is a Hold and XNCR is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 19, 2025
Stock price -- (PMVP: $1.02 vs. XNCR: $9.70)
Brand notoriety: PMVP and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PMVP: 72% vs. XNCR: 78%
Market capitalization -- PMVP: $52.97M vs. XNCR: $683.48M
PMVP [@Biotechnology] is valued at $52.97M. XNCR’s [@Biotechnology] market capitalization is $683.48M. The market cap for tickers in the [@Biotechnology] industry ranges from $282.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PMVP’s FA Score shows that 0 FA rating(s) are green whileXNCR’s FA Score has 1 green FA rating(s).

  • PMVP’s FA Score: 0 green, 5 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, both PMVP and XNCR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PMVP’s TA Score shows that 5 TA indicator(s) are bullish while XNCR’s TA Score has 5 bullish TA indicator(s).

  • PMVP’s TA Score: 5 bullish, 3 bearish.
  • XNCR’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both PMVP and XNCR are a good buy in the short-term.

Price Growth

PMVP (@Biotechnology) experienced а +17.24% price change this week, while XNCR (@Biotechnology) price change was +22.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.02%. For the same industry, the average monthly price growth was -13.21%, and the average quarterly price growth was -24.46%.

Reported Earning Dates

PMVP is expected to report earnings on Aug 07, 2025.

XNCR is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+7.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XNCR($683M) has a higher market cap than PMVP($53M). PMVP YTD gains are higher at: -32.450 vs. XNCR (-57.789). PMVP has higher annual earnings (EBITDA): -84.3M vs. XNCR (-186.17M). XNCR has more cash in the bank: 498M vs. PMVP (169M). PMVP has less debt than XNCR: PMVP (1.19M) vs XNCR (232M). XNCR has higher revenues than PMVP: XNCR (110M) vs PMVP (0).
PMVPXNCRPMVP / XNCR
Capitalization53M683M8%
EBITDA-84.3M-186.17M45%
Gain YTD-32.450-57.78956%
P/E RatioN/AN/A-
Revenue0110M-
Total Cash169M498M34%
Total Debt1.19M232M1%
FUNDAMENTALS RATINGS
XNCR: Fundamental Ratings
XNCR
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
4
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PMVPXNCR
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
76%
Momentum
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
66%
MACD
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
68%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
72%
Declines
ODDS (%)
Bearish Trend 11 days ago
88%
Bearish Trend 11 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
68%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
78%
View a ticker or compare two or three
Ad is loading...
PMVP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BWEN1.680.03
+1.82%
Broadwind
JFIN10.420.15
+1.46%
Jiayin Group
SSB84.820.91
+1.08%
SouthState Corp
SAND8.490.02
+0.24%
Sandstorm Gold Ltd
ADP293.28-0.86
-0.29%
Automatic Data Processing

PMVP and

Correlation & Price change

A.I.dvisor indicates that over the last year, PMVP has been loosely correlated with RCKT. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if PMVP jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PMVP
1D Price
Change %
PMVP100%
+2.00%
RCKT - PMVP
40%
Loosely correlated
+2.93%
CLLS - PMVP
39%
Loosely correlated
+1.40%
COGT - PMVP
38%
Loosely correlated
+2.34%
XNCR - PMVP
38%
Loosely correlated
+1.89%
CCCC - PMVP
37%
Loosely correlated
+13.64%
More

XNCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XNCR has been loosely correlated with ERAS. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if XNCR jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XNCR
1D Price
Change %
XNCR100%
+1.89%
ERAS - XNCR
53%
Loosely correlated
-0.85%
VCYT - XNCR
52%
Loosely correlated
-1.24%
CRNX - XNCR
52%
Loosely correlated
+2.84%
RCKT - XNCR
51%
Loosely correlated
+2.93%
ACLX - XNCR
50%
Loosely correlated
+2.19%
More